
Sign up to save your podcasts
Or


In this episode of SurgOnc Today®, Julie Hallet, MD, MSc, FRCSC, FSSO, from the University of Toronto and Vice-Chair of the SSO HPB disease site working group is joined by Stefano Partelli, MD, PhD, from Università Vita-Saluta San Raffaele and Els Nieveen van Dijkum, MD, PhD, from Amsterdam UMC. We will delve into the rationale behind the non-operative management of non-functional sporadic pancreatic neuroendocrine tumors (PNETs) as well as the design and results of two prospective studies, ASPEN and PANDORA.
Show Notes:
PANDORA: https://academic.oup.com/bjs/article/108/8/888/6202974
ASPEN (interim analysis): https://academic.oup.com/bjs/article/109/12/1186/6672718?login=false
By Society of Surgical Oncology5
1212 ratings
In this episode of SurgOnc Today®, Julie Hallet, MD, MSc, FRCSC, FSSO, from the University of Toronto and Vice-Chair of the SSO HPB disease site working group is joined by Stefano Partelli, MD, PhD, from Università Vita-Saluta San Raffaele and Els Nieveen van Dijkum, MD, PhD, from Amsterdam UMC. We will delve into the rationale behind the non-operative management of non-functional sporadic pancreatic neuroendocrine tumors (PNETs) as well as the design and results of two prospective studies, ASPEN and PANDORA.
Show Notes:
PANDORA: https://academic.oup.com/bjs/article/108/8/888/6202974
ASPEN (interim analysis): https://academic.oup.com/bjs/article/109/12/1186/6672718?login=false

43,615 Listeners

15,477 Listeners

4,327 Listeners

317 Listeners

496 Listeners

1,306 Listeners

2,442 Listeners

111,863 Listeners

56,489 Listeners

8,498 Listeners

7 Listeners

228 Listeners

277 Listeners

15,815 Listeners

192 Listeners